COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT01959386
Brief Title: A Study of Trastuzumab Subcutaneous in Participants With Human Epidermal Growth Factor Receptor-2 (HER2) Positive Early Breast Cancer (HerSCin)

First Submitted : October 8, 2013
First Submitted that Met QC Criteria : October 8, 2013
First Posted : October 10, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : March 2, 2020
Last Update Posted : March 3, 2020